Company Filing History:
Years Active: 2024-2025
Title: Joseph L Mann: Innovator in Biopharmaceutical Formulations
Introduction
Joseph L Mann is a prominent inventor based in Mountain View, CA (US). He has made significant contributions to the field of biopharmaceutical formulations, holding a total of 5 patents. His work focuses on enhancing the stability and efficacy of antibody compositions, which are crucial in medical treatments.
Latest Patents
Among his latest patents, Mann has developed formulations that utilize polyacrylamide-based copolymers as stabilizing excipients. These copolymers play a vital role in maintaining the pharmacokinetic properties of antibody biopharmaceutical agents. By preventing the adsorption of antibodies to interfaces, they help avoid undesirable aggregation events and preserve the binding activity of the antibodies. This innovation is particularly beneficial for high concentration compositions, ensuring that the antibody remains effective when administered to subjects.
Another notable patent involves polymer excipients that reduce or prevent the aggregation of biologic molecules, including proteins, peptides, and nucleic acids. This technology enhances the thermal stability of these molecules in aqueous formulations, making it applicable for treating conditions such as diabetes through the use of insulin and other proteins.
Career Highlights
Joseph L Mann is affiliated with Leland Stanford Junior University, where he continues to advance research in biopharmaceuticals. His work has garnered attention for its potential to improve therapeutic outcomes in various medical applications.
Collaborations
Mann collaborates with notable colleagues, including Eric Andrew Appel and Caitlin Maikawa, who contribute to the innovative research environment at Stanford.
Conclusion
Joseph L Mann's contributions to biopharmaceutical formulations exemplify the impact of innovative research in medicine. His patents reflect a commitment to enhancing the stability and effectiveness of therapeutic agents, ultimately benefiting patient care.